Loading…
Loading…
NCEL (NewcelX Ltd.) is a recent IPO.
It began trading on October 24, 2025, giving it less than a year of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.
| PRE | Prenetics Global Limited | $25.76 | $437.9M |
| SABS | SAB Biotherapeutics, Inc. | $3.79 | $344.8M |
| SRZN | Surrozen, Inc. | $22.42 | $167.6M |
| CELU | Celularity Inc. | $1.58 | $45.7M |
| KTTA | Pasithea Therapeutics Corp. | $0.56 | $18.7M |
| OCEA | Ocean Biomedical, Inc. | $0.00 | $830.4K |
| CERO | CERo Therapeutics Holdings, Inc. | $0.01 | $476.8K |
| NUWE | Nuwellis, Inc. | $0.89 | $82.0K |
| BACK | IMAC Holdings, Inc. | $0.00 | $1.9K |
| BCTXW | BriaCell Therapeutics Corp. | $0.00 | $1.7K |